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1. Introduction 
Melanoma is a progressive disease that claims many lives each year due to lack of 
therapeutics effective for the long-term treatment of patients. Currently, the best treatment 
option is early detection followed by surgical removal. Cutaneous melanoma continues to 
represent both a challenge and a big paradox among solid tumors: though considerable 
prognostic markers are available, little is known about their biological significance. Recent 
data on the effect of an anti-melanoma target therapy, ipilimumab (Hodi et al, 2010) and new 
anti-BRAF molecules (Flaherty, 2010) raised hope on the treatment of melanoma. However, 
although response rates with small molecule inhibitors are high, most are not durable. 
Moreover, for a large subset of patients, reliable predictive biomarkers especially for 
immunologic modulators have not yet been identified. Progress on the treatment of both 
early and advanced melanoma may depend on identifying additional molecular targets and 
on understanding the mechanisms leading to response or resistance.  
Animal models have been critical in the study of the molecular mechanisms of cancer and in 
the development of new therapeutic agents; nevertheless, there is still much room for 
improvement. The most widely used in vivo model involves the injection of tumor cells in 
the flank of mice. The relevance of each particular model depends on how close it replicates 
the histology, physiological effects, biochemical pathways and metastatic pattern observed 
in the same human tumor type. Numerous models have been developed to study human 
tumorigenesis and its properties, such as proliferation, migration, invasion, neoangiogenesis, 
and metastasis, as well as for the study of anti-cancer treatments. Among others, these 
include in vitro systems such as focus formation in tumor cell culture explants and 
continuous cell lines grown on tissue culture plates, or, alternatively, anchorage-independent 
growth in soft agar. The foregoing experimental models are suitable for studying molecular 
pathways in cell-cell and cell-extracellular matrix interactions that would be difficult to 
dissect in the animal. However they will encounter their limitation in terms that they are not 
particularly amenable to the investigation of interactions of tumor cells with the 
surrounding microenvironment of adjacent normal human cell tissues and structures. It has 
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been shown that tumor progression is associated with extensive remodeling of adjacent 
tissues to provide a supportive environment for tumor growth, angiogenesis, invasion, and 
metastasis of cancer cells (Hanahan & Weinberg, 2000; Bissell & Radisky, 2001; Fidler 2002; 
Chambers et al, 2002) 
In this chapter we will discuss the role of the microenvironment in the development of 
melanoma. Finally we will discuss the design of in vivo and in vitro models as tools for 
understanding the biology of melanoma as well as their utility for the evaluation of new 
treatments. 
2. Melanoma anatomic clinical types  
There are mainly four types of cutaneous melanoma: 
Superficial spreading melanoma. The most commonly occurring melanoma, it accounts for 
approximately 70% of melanoma cases. It arises at the site of a pre-existing nevus. It affects 
men and women equally but it appears more frequently on the lower extremities in women 
and on the upper back in men. Superficial spreading melanoma often evolves during a 
period of 1 to 7 years.  
Nodular melanoma. Up 15% of the cases and is more common among older males, 
particularly in trunk, head and neck. It is an aggressive type of melanoma due to its 
tendency to grow in depth invading the dermis and giving early metastasis. It evolves in 
months to less than 5 years. 
Lentigo maligna melanoma. Occurs in 5% of the cases. It is diagnosed in the elderly on 
regions of the skin that were overexposed to the sun such as head, neck, and the dorsum of 
hands. This melanoma grows slowly in a radial fashion over a period of 5-20 years. 
Acral lentiginous melanoma. Makes up 8% of the melanoma cases, but it is the most 
common melanoma diagnosed in dark-skinned people. 
Cutaneous head and neck melanomas constitute 12%–21% of melanomas diagnosed 
annually and they have poorer outcomes relative to melanomas of other sites. Among head 
and neck melanomas, scalp/neck melanomas have a greater risk of melanoma-specific 
mortality (Tseng & Martinez, 2010). 
Malignant melanomas may also arise from the melanocytes present at extracutaneous sites 
(noncutaneous melanomas) namely eye, anogenital regions, mucosal surfaces, nail beds, 
conjunctivae, orbit, esophagus, and leptomeninges. Unlike cutaneous melanomas, there is 
lack of association with sun damage, family history and precursor nevi in these neoplasms. 
Noncutaneous melanomas are rare neoplasms with a poor prognosis, they can metastasize 
to lymph nodes, bone, lung, liver, spleen, gastrointestinal tract, kidneys, adrenals, and 
subcutaneous tissue (reviewed in Hussein, 2008). In this chapter we will focus only in 
cutaneous melanomas.  
3. The role of the microenvironment in the development of cutaneous 
melanoma 
The microenvironment is a key factor in tumor progression. Poorly aggressive melanoma 
cells acquired a vasculogenic phenotype when they were exposed to a microenvironment 
preconditioned by aggressive metastatic melanoma cells (Seftor et al, 2006). The opposite 
effect has also been studied long ago by Illmensee & Mintz (1976) who showed that 
teratocarcinoma cells could be normalized by the blastocyst environment. Melanoma 
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metastatic cells could be reverted to its cell type of origin, the neural-crest-derived 
melanocyte using an embryonic chick model (Kasemeier-Kulesa et al, 2008). Thus this 
evidence shows that whether a melanocyte remains normal or progresses to a neoplastic 
state would depend on the microenvironment, indicating that clues to understand the 
etiology of melanoma should be found at the tissue level of organization (Sonnenschein & 
Soto, 1999) 
The frequency of melanoma tumors appears to be site -specific but yet this phenomenon is 
not well understood. Thus, we will analyze whether the characteristics of the skin of various 
anatomic sites might account for the different types of melanoma. Particularly we will focus 
on the cellular components, reactivity and biomechanical properties of the skin in distinct 
anatomic sites. 
The human skin consists of a stratified, cellular epidermis and an underlying dermis of 
connective tissue. The dermal–epidermal junction is undulating in section; ridges of the 
epidermis project into the dermis. The junction provides mechanical support for the 
epidermis and provides a partial barrier against exchange of cells and large molecules. A 
fatty layer underlies the dermis, the panniculus adiposus, usually designated as 
“subcutaneous”. The major cellular components of the epidermis are keratinocytes, 
melanocytes, Langerhans cells, Merkel cells, and  dendritic cells, and in the dermis, 
fibroblasts, mast cells, macrophages and micro-vascular cells (endothelial cells and smooth 
muscle cells) and adipocytes in the underlying layer (McGrath et al, 2010). 
Skin fibroblasts from different anatomic sites have distinct phenotypes, a phenomenon 
called topographic differentiation, which is maintained even after fibroblasts are isolated 
and cultured in vitro. A differential expression of HOX proteins which are involved in site-
specific organization and in the migration of epidermal cells through integrins and 
cadherins was described. HOXA13 was expressed in toe and foreskin fibroblasts while 
HoxD9 was expressed in upper arm fibroblasts (Chang et al, 2002). Fibroblasts derived from 
soles and palms differ from those at other body sites. Interestingly, expression of keratin 9 
was not observed in cultured non-palmoplantar keratinocytes when cultured alone or with 
non-palmoplantar fibroblasts. However, those keratinocytes expressed keratin 9 mRNA 
when co-cultured with palmoplantar fibroblasts, indicating that the phenotype of 
keratinocytes is anatomically-dependent. Failed migration of melanocytes and pigmentation 
in palms and soles appears to be regulated by the fibroblasts (Yamaguchi et al, 1999, 2005). 
Indeed, melanocyte density in the trunk skin of Caucasians, Asians and African-Americans 
was found to be similar, but was five-fold lower in palmoplantar skin.  
Fibroblasts and keratinocytes also seem to participate in the development of melanomas 
from pre existent nevi (Coleman & Lugo, 1998; Fiuraskova et al, 2005), such as in the case of 
superficial spreading melanomas.  
A type of dendritic cells, the Langerhans cells, are thought to play an important role in skin 
immunity. Studies in inflammatory ear skin explants of mice showed that migrating 
Langerhans cells were able to stimulate CD8+ T cell responses (reviewed in Stoitzner 2010). 
Another study showed that the antigenic response was dependent on Langerhans cells 
when the antigen was applied to the flank, but not when applied to the ear skin of mice 
(Wang et al, 2008). In the human the number of Langerhans cells in hair-bearing skin (chest, 
scalp and abdomen) is higher compared to hairless skin (palm and sole). On the other hand, 
higher numbers of Langerhans cells were found in the dorsum of the hand and foot 
compared to palm and sole (Thomas et al, 1984). The role of Langerhans cells is still 
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controversial, pointing out that it might be equally strongly dependent on both the anatomic 
site and the condition of the skin. 
Mast cells play an active role in inflammatory and allergic reactions. They also participate in 
tissue remodeling; through the releasement of histamine they control the growth of the 
epidermis by inhibiting the growth of keratinocyte epithelium. Histamine induces the 
production of MMP-9 in keratinocytes thereby facilitating the migration of immune cells, 
such as T cells, across the vascular basement membrane or into the epidermis during skin 
inflammation (reviewed in Harvima, 2008). Morever, human skin mast cell extracts have 
proven to enhance gel contraction in 3-D cultures of skin fibroblasts possibly by inducing 
collagen production and organization (Garbuzenko et al, 2002). A study showed that mast 
cells distribution in normal adult skin is site dependent. Higher numbers were found in the 
distal extremities, forearm and lower leg, compared with those in the trunk, upper leg, and 
upper arm. Mast cells on the face were not counted (Janssens et al, 2005). 
UV radiation and aging are factors known to predispose to the development of cutaneous 
melanomas. This could be attributed to the onset of an inflammatory condition, particularly 
in the case of UV radiation, as well as to changes in the biomechanical properties of the skin. 
The role of inflammatory reactions in the development of cutaneous melanoma was 
demonstrated in a recent study in volunteers older than 40 years of age. The results 
indicated that the use of aspirin for 5 years or more reduced the risk of cutaneous melanoma 
by almost half (Curiel-Lewandrowski et al, 2011). UVB is a key factor during extrinsic skin 
aging, it induces collagen cleveage changing the structure of the skin. Because the collagen 
network can not be completely reconstituted de novo, skin elasticity is impaired in the long 
term. Indeed, in a study where human dermal fibroblasts cultured in 3-D collagen gels were 
irradiated with UVB it was shown that collagen degradation inhibited the synthesis of 
hyalorunic acid by the fibroblasts (Röck et al, 2011). Thus it is most likely that photoaging 
alters the extracellular matrix, which in turn induces changes on the phenotype of the 
embedded cells such as keratinocytes, fibroblasts and dendritic cells.  
The biomechanical properties of the skin such as thickness and extensibility decrease with 
age, most likely due to a degeneration of the collagen network and the loss of 
glycosaminoglicans. This is particularly true in sun exposed areas on the face and neck 
(Escoffier et al, 1989; Cua et al, 1990), coincidently with the site of preference of melanomas 
with poorer prognosis. In a different study shoulder skin resulted to be thicker than thighs 
and calves skin (Smalls et al, 2006).  
4. Building models to study the biology of melanoma 
4.1 In vivo models 
Since the microenvironment plays a key role in cancer development, accurate models for the 
study of melanoma should take into account the differential features of the anatomic sites of 
the skin. The most widely used in vivo model for the study of melanoma is the inoculation of 
tumor cells in the flank of mice. In a previous work we investigated whether the dermis of a 
different anatomical site of mice would offer different characteristics than those of the flank. 
Thus, we chose the dorsal region of the foot and compared it to the flank in terms of cellular 
influx and reactivity (Speroni et al, 2009a). We further compared the acute and chronic 
inflammatory response in the selected areas of the skin in order to gain better understanding 
of the reactivity of both anatomic sites. 
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4.1.1 The inflammatory response in distinct anatomic sites of the skin of mice 
4.1.2 Nonspecific inflammatory response  
We tested the acute inflammatory response of the two anatomic sites induced by an extract 
of lung homogenate in Balb/c mice. The release of histamine and bradykinin by mast cells 
induces edema after 2-3 h that persists for up to 24 h post injection. A 0.1 mg/ml lung 
homogenate (Van den Brenk et al, 1974) was prepared and 0.05 ml of this suspension was 
intradermically injected in the dorsal region of the foot and in the flank of Balb/c mice. 
Swelling was recorded as skin thickness using a dial micrometer (Pocotest, GESSH) and 3 mm2 
of skin from the injected site were excised and weighted. Controls were inoculated with PS.  
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Fig. 1. Inflammatory response of the skin following lung homogenate (LH) injection. (A) 
weight and (B) thickness of the inoculated dermis of flank and dorsal region of the foot were 
recorded 4 and 24 h post injection (n=4). *, p<0.05; **, p<0.005; ***p<0.001 significant 
differences, ns, not significant; student t test 
The injection of lung homogenate induced a significant inflammatory response in the dorsal 
region of the foot as evidenced by the significant increase in weight and thickness of the 
injected site. The edema persisted up to 24 h post injection. To the contrary, the skin from 
the flank did not show a significant response to the same inflammatory stimulus, weight 
and thickness were comparable to controls (Figure 1) (non published results). 
The ability of the skin to respond to a chronic inflammatory stimulus was also tested. The 
injection of silica produces a granuloma due to a continuous lysis of macrophages in the 
injection site (Kessel et al, 1963). A suspension of 1 mg of silica in 0.05 ml of PS was 
intradermically injected in the flank and in the dorsal region of the foot of Balb/c mice. 
Local inflammation was recorded as thickness of the injected site using a dial micrometer 
(Pocotest, GESSH).  
The response to silica (Figure 2) was significantly higher in the dermis of the dorsal region 
of the foot than in the dermis of the flank. Moreover in the dorsal region of the foot the 
response was sustained until 10 days after inoculation while in the flank was almost 
undetectable by that time. This result shows that the dermis of the dorsal region of the foot 
is more responsive to a chronic inflammatory stimulus than the dermis of the flank (non 
published results). 
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Fig. 2. Chronic inflammatory response to silica in the dermis of the flank and dorsal region 
of the foot (n=4) * p<0.05; ** p<0.005, Student t test between each group and control 
4.1.3 Specific immune response  
In a previous work we tested the immune response in both anatomic sites after injection of 
sheep red blood cells (SRBC). Seven days after immunization with SRBC, sera was obtained 
and antibody titer was analyzed by hemagglutination assay. We found that a significantly 
higher antibody titer was obtained when SRBC were inoculated in the dorsal region of the 
foot than in the flank (Speroni et al, 2009a). 
Since different levels of inflammatory and immune response were observed, we further 
evaluated the growth of B16F0 melanoma in both anatomic sites.  
4.1.4 Melanoma growth in different anatomic sites of the skin of mice 
The development of B16F0 melanoma in the dorsal region of the foot showed a more 
malignant phenotype than when growing in the flank (Figure 3). The tumor in the flank 
(Figure 3A) showed large and numerous necrotic areas with leukocytic infiltration. Cells 
were disposed in an acinar-like structure, and intratumoral vascularization was scarce or 
absent. On the other hand, melanoma growing in the dorsal region of the foot (Figure 3B) 
showed a different architecture. Cells were distributed in irregular masses. High 
vascularization, and numerous inflammatory cells and hemosiderin deposits were observed. 
Another important difference with tumors growing in the flank was the absence of necrotic 
areas. Macroscopic and histological post-mortem examination of serial lung sections from 
hosts bearing B16F0 tumors showed neither macroscopic nor microscopic metastatic foci. 
Conversely, lung metastases were observed in 100% hosts bearing melanoma tumors in the 
dorsal region of the foot that survived beyond day 14 p.i. (mean) (Speroni et al, 2009a). 
Importantly the hosts of tumors in the dorsal region of the foot had a poor survival 
compared to the hosts of flank tumors (Speroni et al, 2009a). 
Our results clearly show that, even though the tumor cell line was the same, when injected 
in the mice, these cells originate remarkably different tumors which malignancy is dependent 
on the anatomic site of the skin. The skin of the dorsal region of the foot displayed a higher 
inflammatory and immune response most likely due to a higher cellular influx (Speroni et al, 
2009a) than the flank skin. It is clear that several limitations exist with mouse models, 
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particularly with the standard subcutaneous injection for the study of human cancer (Crnalic 
et al, 1997; Hirst & Balmain, 2004; Vitale et al, 2007). We have developed an alternative model 
to the standard inoculation of tumors into the flank of mice that, being equally easy to 
handle, might prove a better model for the study of melanoma progression and metastases 
(Speroni et al, 2009a; 2009b). Moreover, the model of tumor implantation in the dorsal region 
of the foot could be useful for the study of spontaneous metastases from tumors that do not 
originate metastases with the standard method of inoculating tumor cells in the flank. 
 
   
                                     (a)                                                                              (b) 
Fig. 3. Histological analysis of tumors. Sections stained with hematoxylin-eosin from B16F0 
tumor growing in the flank (a) and in the dorsal region of the foot (b). Original magnification 
10X 
4.2 In vitro models 
Building more complex in vitro models of melanoma could improve our understanding on 
the initiation and different stages of the disease. Fibroblasts, one of the principle cell types of 
the stromal compartment, have shown to induce melanoma progression and invasion. The 
interaction between melanoma cells and fibroblasts creates a tumor promoting environment 
by the up-regulation of chemokines, cytokines, and growth factors. Factors secreted by 
fibroblasts and melanoma cells modulate collagen synthesis and promote tumor cell 
chemotaxis and invasion (Van Kempen et al, 2007). Moreover the invasive capacity of human 
melanoma cells is enhanced by the presence of fibroblasts (Bartolome et al, 2004; Li et al, 
2009; Wandel et al, 2002). This culminates in an environment that supports growth and 
invasion. Cells growing in a 3D (three-dimensional) architecture resemble the in vivo situation 
more closely than do cells in conventional 2D cultures (monolayer). Because they can be 
finely tuned they offer the unique opportunity to dissect the molecular pathways and 
signaling between cell-cell and cell-extracellular matrix interaction. Moreover they could 
serve as a useful tool for the assessment of the drug efficacy in the treatment of melanoma in 
different stages.  
5. Conclusion 
The microenvironment plays a key role in tumor development to an extent that it poses the 
question whether a shift of paradigm in biology is needed in order to truly understand the 
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phenomenon of cancer. The plasticity of cells is such that a cell adapts its phenotype 
according to what the systems imposes, i.e. the organization of the tissue and ultimately the 
self-organization of the system. In other words, the identity of a cell is not an intrinsic 
property of it but rather a condition dictated by spatio-temporal cues of the environment.  
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